General Information of Drug Off-Target (DOT) (ID: OT6OCR3H)

DOT Name Voltage-dependent calcium channel gamma-1 subunit (CACNG1)
Synonyms Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma
Gene Name CACNG1
Related Disease
Postmenopausal osteoporosis ( )
UniProt ID
CCG1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13903
Sequence
MSQTKMLKVRVTLFCILAGIVLAMTAVVTDHWAVLSPHMEHHNTTCEAAHFGLWRICTKR
IPMDDSKTCGPITLPGEKNCSYFRHFNPGESSEIFEFTTQKEYSISAAAIAIFSLGFIIL
GSLCVLLSLGKKRDYLLRPASMFYAFAGLCILVSVEVMRQSVKRMIDSEDTVWIEYYYSW
SFACACAAFILLFLGGLALLLFSLPRMPRNPWESCMDAEPEH
Function Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Regulates channel inactivation kinetics.
Tissue Specificity Skeletal muscle.
KEGG Pathway
MAPK sig.ling pathway (hsa04010 )
Cardiac muscle contraction (hsa04260 )
Adrenergic sig.ling in cardiomyocytes (hsa04261 )
Oxytocin sig.ling pathway (hsa04921 )
Hypertrophic cardiomyopathy (hsa05410 )
Arrhythmogenic right ventricular cardiomyopathy (hsa05412 )
Dilated cardiomyopathy (hsa05414 )

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Postmenopausal osteoporosis DISS0RQZ Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Voltage-dependent calcium channel gamma-1 subunit (CACNG1). [2]
Niclosamide DMJAGXQ Approved Niclosamide increases the expression of Voltage-dependent calcium channel gamma-1 subunit (CACNG1). [3]
Aspirin DM672AH Approved Aspirin decreases the expression of Voltage-dependent calcium channel gamma-1 subunit (CACNG1). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Voltage-dependent calcium channel gamma-1 subunit (CACNG1). [5]
------------------------------------------------------------------------------------

References

1 In silico analysis of the molecular mechanism of postmenopausal osteoporosis.Mol Med Rep. 2015 Nov;12(5):6584-90. doi: 10.3892/mmr.2015.4283. Epub 2015 Sep 2.
2 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
3 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
4 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.